EPHA2 and pancreatic neoplasm: At the same time, the expression level of EphA2 on serum sEVs was also significantly increased in patients with pancreatic cancer, and the expression level of these vesicles in advanced patients (III and IV) was significantly higher than that in early patients (I and II) (87).